4//SEC Filing
NEWTON ROGER S 4
Accession 0001179110-18-012267
CIK 0001434868other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 5:05 PM ET
Size
8.7 KB
Accession
0001179110-18-012267
Insider Transaction Report
Form 4
NEWTON ROGER S
DirectorExecutive Chairman, CSO
Transactions
- Sale
Common Stock
2018-10-17$50.02/sh−12,673$633,903→ 576,653 total - Sale
Common Stock
2018-10-18$50.00/sh−100$5,000→ 576,553 total - Sale
Common Stock
2018-10-16$50.01/sh−9,400$470,094→ 589,326 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 21, 2018.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.08, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.16, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeother
Related Parties
1- filerCIK 0001242612
Filing Metadata
- Form type
- 4
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 5:05 PM ET
- Size
- 8.7 KB